Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
ICS verlagen SARS-CoV-2-gerelateerde genen bij COPD
nov 2021 | COPD, Virale infecties